ICCC ImmuCell: יחס שווי שוק לערך בספרים

ImmuCell Corporation (ICCC) is managed by experienced veterinary biotechnology experts focused on increasing profitability and protecting patents. This chart's price trend confirms the current momentum, where the indicator stands at 2.94. The business relies on external contractors for drug manufacturing and logistics, yet faces dependency on a single plant and demand fluctuations within the US livestock industry.

ImmuCell Corporation (ICCC) is advancing ecological veterinary medicine by reducing the livestock industry's dependence on antibiotics. Analyzing the current price-to-book multiple trend allows for an assessment of the market's recognition of these innovations. This metric compares the total equity value with the net assets on the balance sheet. A value above one indicates a premium for future growth, while a value below one suggests an undervaluation of assets. This enables a determination of the company's actual capital safety margin.